Literature DB >> 15710826

New therapy for central retinal vein occlusion: are intravitreal steroids a possible answer?

Mark S Blumenkranz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15710826     DOI： 10.1001/archopht.123.2.259

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  3 in total

1.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.

Authors:  Michael S Ip; Ingrid U Scott; Paul C VanVeldhuisen; Neal L Oden; Barbara A Blodi; Marian Fisher; Lawrence J Singerman; Michael Tolentino; Clement K Chan; Victor H Gonzalez
Journal:  Arch Ophthalmol       Date:  2009-09

2.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.

Authors:  Ingrid U Scott; Michael S Ip; Paul C VanVeldhuisen; Neal L Oden; Barbara A Blodi; Marian Fisher; Clement K Chan; Victor H Gonzalez; Lawrence J Singerman; Michael Tolentino
Journal:  Arch Ophthalmol       Date:  2009-09

3.  The effect of intravitreal anti-VEGF agents on peripheral wound healing in a rabbit model.

Authors:  John Christoforidis; Robert Ricketts; Cedric Pratt; Jordan Pierce; Scott Bean; Michael Wells; Xiaoli Zhang; Krista La Perle
Journal:  Clin Ophthalmol       Date:  2012-01-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.